The global cartilage repair market is experiencing robust growth, projected to expand from $1.3 billion in 2023 to $2.8 billion by 2028, at an impressive compound annual growth rate (CAGR) of 17.2%. This burgeoning market is fueled by several key factors, including the rising prevalence of osteoarthritis worldwide and increasing growth opportunities in emerging economies.

A Mounting Osteoarthritis Burden

Osteoarthritis, a debilitating condition characterized by the degeneration of cartilage in joints, has emerged as a significant driver of the cartilage repair market. According to the World Health Organization, in 2019, an estimated 528 million people worldwide were living with osteoarthritis, a staggering 113% increase since 1990. Furthermore, a recent study published in The Lancet revealed that a concerning 15% of the global population over the age of 30 suffers from this condition.

As the population ages and obesity rates continue to rise, the burden of osteoarthritis is expected to escalate further. By 2050, nearly 1 billion individuals are projected to be affected by this debilitating condition. Consequently, the demand for effective cartilage repair and regeneration products, such as autologous chondrocyte implantation and scaffold implants, is anticipated to surge.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272

Technological Advancements Pave the Way

The cartilage repair market is also benefiting from continuous technological advancements in the field. Ongoing research and development efforts are focused on identifying universal sources of progenitor cells, such as embryonic and induced pluripotent stem cells, for cartilage regeneration. While challenges like immune rejection, tumorigenesis, and teratoma formation remain, regulatory bodies like the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and the Central Ethics Committee for Stem Cell Research are working to ensure the safe and ethical use of these technologies.

Key Market Segments and Regional Dynamics

The cartilage repair market is segmented based on various factors, including treatment modalities, applications, and application sites. In 2022, the hyaline cartilage segment experienced the highest growth rate, driven by an increasing number of contracts and agreements between key market players, as well as rising investments in research and development of tissue-engineered products for cartilage injury or damage treatment.

Geographically, North America dominates the cartilage repair market, primarily due to the high prevalence of knee-related conditions and the subsequent demand for knee arthroscopy procedures. Major players in the market include industry giants such as Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), and Vericel Corporation (US).

Challenges and Opportunities

While the cartilage repair market presents significant growth opportunities, it is not without its challenges. One notable barrier is the high cost of cartilage repair surgeries, which can range from $18,000 to $23,000, significantly higher than the average cost of a total knee replacement surgery ($16,000). This cost factor may limit the adoption of cartilage repair procedures, particularly in developing countries with limited healthcare resources.

However, the market also presents attractive opportunities for growth, driven by technological advancements and the development of innovative cartilage repair solutions. As research progresses and costs potentially decrease, the cartilage repair market is poised to experience substantial growth, offering hope for millions of individuals suffering from osteoarthritis and other cartilage-related conditions.

Cartilage Repair / Cartilage Regeneration Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 17.2% from 2023 to 2028 according to a new report by MarketsandMarkets. Growth in the Cartilage Repair/Cartilage Regeneration market is mainly driven by the increasing prevalence of sports and accident-related orthopedic injuries and the increasing number of osteoarthritis cases expected to offer growth opportunities for players operating in the Cartilage Repair/Cartilage Regeneration market during the forecast period. However, the High cost of cartilage repair surgeries and Unfavorable reimbursement scenarios are restricting the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272

Key Market Players of Cartilage Repair / Cartilage Regeneration Industry:

The Key players in the Cartilage Repair/Cartilage Regeneration market are Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Vericel Corporation (US), B. Braun Melsungen AG (US), Anika Therapeutics (US), CONMED Corporation (US), MEDIPOST (South Korea), RTI Surgical (US), Arthrex, Inc. (US), Regrow Biosciences (India), Geistlich Pharma AG (Switzerland), AlloSource (US), Orthocell Ltd, (Australia), Matricel GmbH (Germany), CartiHeal, Inc. (Israel), Regentis Biomaterials (Israel), Theracell Advanced Biotechnology (Greece), and LifeNet Health (US).

By treatment modality the Cartilage Repair/Cartilage Regeneration market is divided into Cell-based and non-cell-based categories where cell-based segment includes chondrocyte transplantation, stem cells and growth factors. The non-cell-based which are the scaffolds and cell-free composites. Cell-based including chondrocyte transplantation, growth factors, and stem cells will drive the growth of the market due to the increasing number of osteoarthritis cases.

By Application, the global Cartilage Repair/Cartilage Regeneration market is broadly segmented into hyaline cartilage and fibrocartilage. Hyaline cartilage is expected to grow highest in the upcoming years. The increasing number of hospitals and advancement in cartilage repair products will drive the growth of this application segment. Technological advancements, product developments and launches, and growing partnerships between key market players and hospitals are also supporting market growth.

By application site, the global Cartilage Repair/Cartilage Regeneration market is broadly segmented into knee, hip, ankle & foot, and other application sites (nose and shoulder). The knee is expected to grow highest in the upcoming years. The increasing number of Knee replacement procedures performed worldwide is the major factor driving the growth of this application site segment. For Instance, according to the American Orthopedic Society for Sports Medicine, over 4 million knee arthroscopy procedures are performed worldwide each year; 700,000 are conducted in the US.

Based on the region, the Cartilage Repair/Cartilage Regeneration market is segmented into North America, Europe, Asia Pacific and Rest of the world. The North American market is driven by the growing focus on growing government and private investments. For instance, In March 2020, the Government of Canada granted USD 6.9 million through the Stem Cell Network’s competitive research funding, a body that supports Canada’s most promising stem cell research. This funding is channelized to support nine translational projects and four clinical trials across Canada’s regenerative medicine market, which comprises 200 researchers and trainees at 27 Canadian research institutes in Alberta, British Columbia, Quebec, and Ontario, as well as direct partnerships with several emerging biotechnology companies.

Cartilage Repair / Cartilage Regeneration Market Dynamics:

Drivers:

1. Increasing number of osteoarthritis cases

Restraints:

1. High cost of cartilage repair surgeries

Opportunities:

1. Technological advancements

Challenge:

1. Limitations of cartilage-based stem cell products